|
Product Approval Information - New Drug Application
Product name: Urokinase (Abbokinase)
Manufacturer: Abbott Laboratories, Abbott Park, IL
Intended Use: for adults for the lysis of acute massive pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments, and for the lysis of pulmonary emboli accompanied by unstable hemodynamics, i.e., failure to maintain blood pressure without supportive measures
Approval Date: 10/10/2002
Type of submission: New Drug application supplement
Approval Letter -
(Text)
Label -
(PDF)
(Text)
Other Information on Urokinase
Last Updated: 11/22/2002
 Back
to Top 
Back to Index
Updated: September 26, 2003 |
